Arkayli Biopharma, Inc.

Madison, WI

UEI
Y569SLYB1EJ9
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
133 N Prospect Ave, Madison, WI 53726, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Arkayli Biopharma, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Developing a topical beta blocker formulation as a targeted therapeutic for infantile hemangioma - project summary /… Grant · R41HL177866 National Heart Lung and Blood Institute $306,804

Quick answers

What is Arkayli Biopharma, Inc.'s UEI?

Arkayli Biopharma, Inc.'s Unique Entity ID (UEI) in SAM.gov is Y569SLYB1EJ9.

Where is Arkayli Biopharma, Inc. located?

Arkayli Biopharma, Inc.'s physical address in SAM.gov is 133 N Prospect Ave, Madison, WI 53726, USA.

Is Arkayli Biopharma, Inc. registered in SAM.gov?

Yes. Arkayli Biopharma, Inc.'s SAM.gov registration is active through December 29, 2026.

What is Arkayli Biopharma, Inc.'s most recent federal award?

Arkayli Biopharma, Inc.'s most recent federal grant award is Developing a topical beta blocker formulation as a targeted therapeutic for infantile hemangioma - project summary /… (R41HL177866), from National Heart Lung and Blood Institute, on June 1, 2025.

On GovTribe

See Arkayli Biopharma, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login